Renal Solutions, Inc. Announces Acquisition by Fresenius Medical Care
WARRENDALE, Pa., Nov. 29 /PRNewswire/ -- Renal Solutions, Inc. (RSI)
announced today that the Company has been acquired by Fresenius
Care AG & Co. KGaA. RSI will continue operations as a wholly owned
subsidiary of Fresenius
Medical Care, the largest integrated global
provider of dialys...
Dialysis Clinics Owned By Fresenius Flourishes Due To Its Customers Fresenius
is a Germany-based dialysis service clinic. It’s got its branch across the globe. American depositary shares of German dialysis giant Fresenius// Medical Care climbed 46.9% $25.85. It follows that treating this grave condition can be a lucrative business.
Kidney failure affects the po...
Texas Kidney Community: CMS Authorization to Survey 22 New Dialysis Centers Excellent First Step Toward Opening Additional Pending Facilities, Creating More Local Jobs
...est to greatly improve access to quality dialysis care for patients in these 22 affected communities," said Robert Hootkins, M.D., medical director of fresenius
Medical Care Austin North. "The end result will be better dialysis care for ESRD patients and more jobs for Texans - we applaud their action."
SEEBURGER Offers First B2B Integration between SAP & ePedigree Systems
to Discuss EDI/ePedigree Strategy at 2009 ASUG Ann...ment - involving integration with SAP R/3 at fresenius
Medical Care North America - and the operational... ePedigree Compliance" will be led by Wally Slone, fresenius
VP of Business Systems, and Stefan Koenig, SEEBURG...
Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group
...t's Venofer continues to hold the position as market leader among CKD patients. In the hemodialysis market, use of Watson's Ferrlecit decreased while fresenius
Medical Care's Venofer, the market leader, experienced share growth year over year. The greatest share growth came from Nephrologists primarily affil...
Preparing for the Next Disaster: Dialysis Community Briefs Hill About Emergency Response
...nt Commander for Disaster Planning and Response at fresenius
Medical Care North America (FMCNA).
...nt Commander for Disaster Planning and Response at fresenius
Medical Care North America (FMCNA). Numbers was in...idney Community Emergency Response Coalition and fresenius
Medical Care looked at the problem of Chronic Kid...
Australia's Leading Oncology Drug Compounder Chooses RIVA System
... WINNIPEG, Feb. 11 /PRNewswire/ - Pharmatel fresenius
Kabi Pty Ltd, one of Australia's fastest growing a...tems) to consolidate its IV preparation. Pharmatel fresenius
Kabi will take delivery of its first RIVA unit in June 2009.
The RIVA System and Pharmatel fresenius
Kabi's continued investment in specialized sterile...
NxStage Applauds Array of Studies To Be Presented at American Society of Nephrology Meeting
... quality-of-life (HR-QOL) including over 41,000 in-center HD patients and approximately 2,300 home HD and PD patients gathered in 2006 in fresenius
Medical Care North America facilities, and concludes that both physical and mental HR-QOL scores are significantly higher in home patients, ...
Retired Respironics Chairman Jerry McGinnis and Renal Solutions CEO Pete DeComo Join ALung Technologies Board of Directors; ALung Closes on $1 Million Bridge Financing
Pete DeComo became the chief executive officer of Renal Solutions, Inc.
(RSI), a wholly owned subsidiary of fresenius
Medical Care Holdings (FMCHI)
subsequent to an acquisition and merger on November 26, 2007. Prior to this
he was the chairman, chief executive officer...
Fresenius Medical Care Supports Chinese Earthquake Victims
... SHANGHAI, China, June 10 /Xinhua-PRNewswire/ -- fresenius
is offering its assistance to the ear...ls and aid organizations in the region.
Teams of fresenius
Medical Care employees have delivered, for example...the installation and proper usage of the
Medical Care China is also supporting various aid
Fresenius in Medical Technology
Fresenius in Biological Technology
BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
...e from the recent introduction of generic calcium acetate from Roxane Laboratories, as very few Nephrologists oppose the substitution of a generic for fresenius
Medical Care's PhosLo. Another recent market shift came with the introduction of Genzyme's Renvela in Q108. Although the growth of Renvela seems to ...
NASDAQ OMX AeA Illinois Tech Index Outperforms Market
...agle Test Systems, Inc. by Teradyne, Inc., the acquisition of NAVTEQ Corporation by Nokia Corporation, and acquisition of APP Pharmaceuticals, Inc. by fresenius
SE. There were no additions to the index in 2008.
The top ten index constituents include Abbott Laboratories 37.40%, Baxter International Inc. 1...
Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors
... a consultant to several east coast venture capital firms and startup venture companies. From 1998 to 2001, Dr. Stoll was Executive Vice-President of fresenius
Medical Care - North America, a leading manufacturer and distributor of dialysis products, including hemodialysis machines and filters, and operator o...
BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
...re's Fosrenol does its best in Davita units whereas
PhosLo does its best in fresenius
units. Nephrologists are divided as to
their first line preference in dialy...e in the past year,
although 60% of Nephrologists primarily affiliated with fresenius
expect their use of Venofer to increase following the news that Frese...
BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
...r Shire's Fosrenol. Concern with
lanthanum absorption has fallen in recent quarters and is of significantly
less concern than calcium absorption. Both fresenius
Medical Care's PhosLo
and calcium carbonate continue to be impacted by concerns with calcium,
although calcium binders are expected to remain the pref...
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...O (Tokyo SE: 4506) EXELIXIS INC (NASDAQ: EXEL ) fresenius
SE (Frankfurt, Germany: FRE) GEDEON RICHTER PLC (...OB) EGIS PHARMACEUTICA (Budapest, Hungary: EGIS) fresenius
SE (Frankfurt, Germany: FRE) GALENICA AG (SWX, Sw...-VORZ AKT (Frankfurt Stock Exchange: DRW3)
SE (Frankfurt, Germany: FRE) PHOTOCURE ASA (Oslo,...
Illinois Pharmaceutical Manufacturer Sued for Injuries to Kentucky Resident
...e and single-dose vials,
as well as HEP-LOCK Heparin Flush Products.
In January of 2008, Mr. Banks received a box of 25 vials of Baxter
Heparin from fresenius
Medical Care for use during home dialysis
treatments. Banks used the product as prescribed but began experiencing
numerous physical symptoms, such as ...
BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
...in dialysis and Fosrenol's share is expected to significantly increase in
this population. In the CKD setting, calcium-based binders are preferred
Medical Care's PhosLo is the market share leader with 43%
share. Genzyme launched Renvela (sevelamer carbonate) the first week in
March. The majority ...
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
...oCare Corp. (Nasdaq: ARTC ) Endo Pharmaceuticals Hldgs. (Nasdaq: ENDP ) fresenius
Medical Care AG (XETRA: FME.DE) GEDEON RICHTER RT (XETRA: R1G1.DE) GENMAB...King Pharmaceuticals (NYSE: KG ) Patient Care Services Index (HHB) Drop fresenius
Medical Care (XETRA: FME.DE) Add Coventry Health Care Inc. (NYSE: CVH ) ...
BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
..., translated into
increased use of binders over the past year. Binder preference also remains
similar to last year with calcium-based binders (such as fresenius
Care's PhosLo) dominating 2:1 in the pre-dialysis setting, whereas in the
dialysis market, the shift to non-calcium agents (such as Genzyme's ...